Research and Development Agreements - Schedule of Research and Development Revenue from Related Party Relates to Revenue from Research and Development Agreements (Detail)

v3.23.1

Research and Development Agreements - Schedule of Research and Development Revenue from Related Party Relates to Revenue from Research and Development Agreements (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Revenue Recognition [Line Items]
Research and development revenue recognized	$ 2,600	$ 19,754	$ 38,697
Millennium Pharmaceuticals, Inc.
Revenue Recognition [Line Items]
Research and development revenue recognized		2,586	13,136
Millennium Pharmaceuticals, Inc. | Takeda Development Agreement
Revenue Recognition [Line Items]
Research and development revenue recognized		0	13,114
Millennium Pharmaceuticals, Inc. | Takeda Multi Target Agreement
Revenue Recognition [Line Items]
Research and development revenue recognized		$ 2,586	$ 22